aluates Reports

$ 0.0

Automative

Global Chronic Thromboembolic Pulmonary Hypertension Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-13N6290

Global Chronic Thromboembolic Pulmonary Hypertension Market Insights and Forecast to 2028

BUY CHAPTERS

Global Chronic Thromboembolic Pulmonary Hypertension Market Research Report 2025

Code: QYRE-Auto-13N6290

Report

September 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Johnson & Johnson

Nippon Shinyaku

GlaxoSmithKline PLC

Sun Pharmaceutical Industries

SciPharm SaRL

Promedica International

Medical Research Network

Gilead Sciences

Daiichi Sankyo

Johnson & Johnson

Chronic Thromboembolic Pulmonary Hypertension Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Chronic Thromboembolic Pulmonary Hypertension Market

The global market for Chronic Thromboembolic Pulmonary Hypertension was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical condition in which pulmonary vascular resistance increases giving rise to pulmonary hypertension and progressive heart failure. According to World Health Organization (WHO), approximately 0.15% to 0.55% of the patients suffering with acute pulmonary embolism develop chronic thromboembolic pulmonary hypertension. Due to non-specific symptoms observed in chronic thromboembolic pulmonary hypertension its diagnosis is complex. However, some of the prominent symptoms of chronic thromboembolic pulmonary hypertension are chest discomfort, breathlessness and fatigue. Chronic thromboembolic pulmonary hypertension market can be segmented on the basis of types of diagnosis such as transthoracic echocardiogram (TTE), ventilation-perfusion (V/Q) scan, pulmonary angiography, heart catheterization, computed tomography (CT) pulmonary angiography and other pulmonary function tests.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Chronic Thromboembolic Pulmonary Hypertension, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Thromboembolic Pulmonary Hypertension.

The Chronic Thromboembolic Pulmonary Hypertension market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Thromboembolic Pulmonary Hypertension market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Thromboembolic Pulmonary Hypertension companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Thromboembolic Pulmonary Hypertension Market Report

Report Metric	Details
Report Name	Chronic Thromboembolic Pulmonary Hypertension Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Transthoracic Echocardiogram (TTE) Ventilation-Perfusion (V/Q) Scan Pulmonary Angiography Heart Catheterization Computed Tomography (CT) Pulmonary Angiography Others
Segment by Application	Hospitals Ambulatory Surgical Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Johnson & Johnson, Nippon Shinyaku, GlaxoSmithKline, Sun Pharmaceutical Industries, Scipharm SaRL, Promedica International, Medical Research Network, Gilead Sciences, Daiichi Sankyo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Thromboembolic Pulmonary Hypertension company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Thromboembolic Pulmonary Hypertension Market report?

Ans: The main players in the Chronic Thromboembolic Pulmonary Hypertension Market are Bayer, Johnson & Johnson, Nippon Shinyaku, GlaxoSmithKline, Sun Pharmaceutical Industries, Scipharm SaRL, Promedica International, Medical Research Network, Gilead Sciences, Daiichi Sankyo

What are the Application segmentation covered in the Chronic Thromboembolic Pulmonary Hypertension Market report?

Ans: The Applications covered in the Chronic Thromboembolic Pulmonary Hypertension Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Chronic Thromboembolic Pulmonary Hypertension Market report?

Ans: The Types covered in the Chronic Thromboembolic Pulmonary Hypertension Market report are Transthoracic Echocardiogram (TTE), Ventilation-Perfusion (V/Q) Scan, Pulmonary Angiography, Heart Catheterization, Computed Tomography (CT) Pulmonary Angiography, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Transthoracic Echocardiogram (TTE)

1.2.3 Ventilation-Perfusion (V/Q) Scan

1.2.4 Pulmonary Angiography

1.2.5 Heart Catheterization

1.2.6 Computed Tomography (CT) Pulmonary Angiography

1.2.7 Others

1.3 Market by Application

1.3.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Perspective (2020-2031)

2.2 Global Chronic Thromboembolic Pulmonary Hypertension Growth Trends by Region

2.2.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chronic Thromboembolic Pulmonary Hypertension Historic Market Size by Region (2020-2025)

2.2.3 Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Region (2026-2031)

2.3 Chronic Thromboembolic Pulmonary Hypertension Market Dynamics

2.3.1 Chronic Thromboembolic Pulmonary Hypertension Industry Trends

2.3.2 Chronic Thromboembolic Pulmonary Hypertension Market Drivers

2.3.3 Chronic Thromboembolic Pulmonary Hypertension Market Challenges

2.3.4 Chronic Thromboembolic Pulmonary Hypertension Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chronic Thromboembolic Pulmonary Hypertension Players by Revenue

3.1.1 Global Top Chronic Thromboembolic Pulmonary Hypertension Players by Revenue (2020-2025)

3.1.2 Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Players (2020-2025)

3.2 Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chronic Thromboembolic Pulmonary Hypertension Revenue

3.4 Global Chronic Thromboembolic Pulmonary Hypertension Market Concentration Ratio

3.4.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Thromboembolic Pulmonary Hypertension Revenue in 2024

3.5 Global Key Players of Chronic Thromboembolic Pulmonary Hypertension Head office and Area Served

3.6 Global Key Players of Chronic Thromboembolic Pulmonary Hypertension, Product and Application

3.7 Global Key Players of Chronic Thromboembolic Pulmonary Hypertension, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Thromboembolic Pulmonary Hypertension Breakdown Data by Type

4.1 Global Chronic Thromboembolic Pulmonary Hypertension Historic Market Size by Type (2020-2025)

4.2 Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Type (2026-2031)

5 Chronic Thromboembolic Pulmonary Hypertension Breakdown Data by Application

5.1 Global Chronic Thromboembolic Pulmonary Hypertension Historic Market Size by Application (2020-2025)

5.2 Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chronic Thromboembolic Pulmonary Hypertension Market Size (2020-2031)

6.2 North America Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2020-2025)

6.4 North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size (2020-2031)

7.2 Europe Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2020-2025)

7.4 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size (2020-2031)

8.2 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2020-2025)

8.4 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size (2020-2031)

9.2 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2020-2025)

9.4 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size (2020-2031)

10.2 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2020-2025)

10.4 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Chronic Thromboembolic Pulmonary Hypertension Introduction

11.1.4 Bayer Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Introduction

11.2.4 Johnson & Johnson Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Nippon Shinyaku

11.3.1 Nippon Shinyaku Company Details

11.3.2 Nippon Shinyaku Business Overview

11.3.3 Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Introduction

11.3.4 Nippon Shinyaku Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.3.5 Nippon Shinyaku Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Introduction

11.4.4 GlaxoSmithKline Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.4.5 GlaxoSmithKline Recent Development

11.5 Sun Pharmaceutical Industries

11.5.1 Sun Pharmaceutical Industries Company Details

11.5.2 Sun Pharmaceutical Industries Business Overview

11.5.3 Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Introduction

11.5.4 Sun Pharmaceutical Industries Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.5.5 Sun Pharmaceutical Industries Recent Development

11.6 Scipharm SaRL

11.6.1 Scipharm SaRL Company Details

11.6.2 Scipharm SaRL Business Overview

11.6.3 Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Introduction

11.6.4 Scipharm SaRL Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.6.5 Scipharm SaRL Recent Development

11.7 Promedica International

11.7.1 Promedica International Company Details

11.7.2 Promedica International Business Overview

11.7.3 Promedica International Chronic Thromboembolic Pulmonary Hypertension Introduction

11.7.4 Promedica International Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.7.5 Promedica International Recent Development

11.8 Medical Research Network

11.8.1 Medical Research Network Company Details

11.8.2 Medical Research Network Business Overview

11.8.3 Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Introduction

11.8.4 Medical Research Network Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.8.5 Medical Research Network Recent Development

11.9 Gilead Sciences

11.9.1 Gilead Sciences Company Details

11.9.2 Gilead Sciences Business Overview

11.9.3 Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Introduction

11.9.4 Gilead Sciences Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.9.5 Gilead Sciences Recent Development

11.10 Daiichi Sankyo

11.10.1 Daiichi Sankyo Company Details

11.10.2 Daiichi Sankyo Business Overview

11.10.3 Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Introduction

11.10.4 Daiichi Sankyo Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

11.10.5 Daiichi Sankyo Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer

Johnson & Johnson

Nippon Shinyaku

GlaxoSmithKline PLC

Sun Pharmaceutical Industries

SciPharm SaRL

Promedica International

Medical Research Network

Gilead Sciences

Daiichi Sankyo

Johnson & Johnson

List of Tables

Table 1. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Transthoracic Echocardiogram (TTE)

Table 3. Key Players of Ventilation-Perfusion (V/Q) Scan

Table 4. Key Players of Pulmonary Angiography

Table 5. Key Players of Heart Catheterization

Table 6. Key Players of Computed Tomography (CT) Pulmonary Angiography

Table 7. Key Players of Others

Table 8. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2020-2025)

Table 12. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2026-2031)

Table 14. Chronic Thromboembolic Pulmonary Hypertension Market Trends

Table 15. Chronic Thromboembolic Pulmonary Hypertension Market Drivers

Table 16. Chronic Thromboembolic Pulmonary Hypertension Market Challenges

Table 17. Chronic Thromboembolic Pulmonary Hypertension Market Restraints

Table 18. Global Chronic Thromboembolic Pulmonary Hypertension Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Players (2020-2025)

Table 20. Global Top Chronic Thromboembolic Pulmonary Hypertension Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Thromboembolic Pulmonary Hypertension as of 2024)

Table 21. Ranking of Global Top Chronic Thromboembolic Pulmonary Hypertension Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Chronic Thromboembolic Pulmonary Hypertension Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Chronic Thromboembolic Pulmonary Hypertension, Headquarters and Area Served

Table 24. Global Key Players of Chronic Thromboembolic Pulmonary Hypertension, Product and Application

Table 25. Global Key Players of Chronic Thromboembolic Pulmonary Hypertension, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Type (2020-2025)

Table 29. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Type (2026-2031)

Table 31. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Application (2020-2025)

Table 33. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Application (2026-2031)

Table 35. North America Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2026-2031) & (US$ Million)

Table 50. Bayer Company Details

Table 51. Bayer Business Overview

Table 52. Bayer Chronic Thromboembolic Pulmonary Hypertension Product

Table 53. Bayer Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 54. Bayer Recent Development

Table 55. Johnson & Johnson Company Details

Table 56. Johnson & Johnson Business Overview

Table 57. Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Product

Table 58. Johnson & Johnson Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 59. Johnson & Johnson Recent Development

Table 60. Nippon Shinyaku Company Details

Table 61. Nippon Shinyaku Business Overview

Table 62. Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Product

Table 63. Nippon Shinyaku Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 64. Nippon Shinyaku Recent Development

Table 65. GlaxoSmithKline Company Details

Table 66. GlaxoSmithKline Business Overview

Table 67. GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Product

Table 68. GlaxoSmithKline Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 69. GlaxoSmithKline Recent Development

Table 70. Sun Pharmaceutical Industries Company Details

Table 71. Sun Pharmaceutical Industries Business Overview

Table 72. Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Product

Table 73. Sun Pharmaceutical Industries Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 74. Sun Pharmaceutical Industries Recent Development

Table 75. Scipharm SaRL Company Details

Table 76. Scipharm SaRL Business Overview

Table 77. Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Product

Table 78. Scipharm SaRL Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 79. Scipharm SaRL Recent Development

Table 80. Promedica International Company Details

Table 81. Promedica International Business Overview

Table 82. Promedica International Chronic Thromboembolic Pulmonary Hypertension Product

Table 83. Promedica International Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 84. Promedica International Recent Development

Table 85. Medical Research Network Company Details

Table 86. Medical Research Network Business Overview

Table 87. Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Product

Table 88. Medical Research Network Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 89. Medical Research Network Recent Development

Table 90. Gilead Sciences Company Details

Table 91. Gilead Sciences Business Overview

Table 92. Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Product

Table 93. Gilead Sciences Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 94. Gilead Sciences Recent Development

Table 95. Daiichi Sankyo Company Details

Table 96. Daiichi Sankyo Business Overview

Table 97. Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Product

Table 98. Daiichi Sankyo Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025) & (US$ Million)

Table 99. Daiichi Sankyo Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Chronic Thromboembolic Pulmonary Hypertension Picture

Figure 2. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Type: 2024 VS 2031

Figure 4. Transthoracic Echocardiogram (TTE) Features

Figure 5. Ventilation-Perfusion (V/Q) Scan Features

Figure 6. Pulmonary Angiography Features

Figure 7. Heart Catheterization Features

Figure 8. Computed Tomography (CT) Pulmonary Angiography Features

Figure 9. Others Features

Figure 10. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Application: 2024 VS 2031

Figure 12. Hospitals Case Studies

Figure 13. Ambulatory Surgical Centers Case Studies

Figure 14. Others Case Studies

Figure 15. Chronic Thromboembolic Pulmonary Hypertension Report Years Considered

Figure 16. Global Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Chronic Thromboembolic Pulmonary Hypertension Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Region: 2024 VS 2031

Figure 19. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Players in 2024

Figure 20. Global Top Chronic Thromboembolic Pulmonary Hypertension Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Thromboembolic Pulmonary Hypertension as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Chronic Thromboembolic Pulmonary Hypertension Revenue in 2024

Figure 22. North America Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2020-2031)

Figure 24. United States Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2020-2031)

Figure 28. Germany Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2020-2031)

Figure 36. China Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2020-2031)

Figure 44. Mexico Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2020-2031)

Figure 48. Turkey Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Bayer Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 52. Johnson & Johnson Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 53. Nippon Shinyaku Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 54. GlaxoSmithKline Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 55. Sun Pharmaceutical Industries Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 56. Scipharm SaRL Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 57. Promedica International Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 58. Medical Research Network Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 59. Gilead Sciences Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 60. Daiichi Sankyo Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pulmonary Embolism Drug Market Research Report 2025

Global Pulmonary Hypertension Drug Market Research Report 2025

Global Mechanical Thrombectomy Catheter Market Research Report 2024

Global Eisenmenger Syndrome Treatment Market Research Report 2024

Global Venous Thromboembolism Therapy Market Research Report 2025

Chronic Pulmonary Hypertension Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Thrombus Aspiration Catheter Market Insights Forecast to 2030

Global Neurovascular Thrombectomy Device Market Research Report 2024

Global Thrombus Management Device Market Research Report 2025

Pulmonary Embolism Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Venous Thromboembolism Therapeutics Market Research Report 2025

Global Pulmonary Edema Treatment Market Research Report 2024

Pulmonary Arterial Hypertension Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Deep Vein Thrombosis Pumps Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Thrombus Aspiration Device Market Research Report 2025

Chronic Pulmonary Hypertension Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Venous Thromboembolism Prophylaxis Market Research Report 2025

Global Vascular Doppler Devices Market Research Report 2025

Medical Consumables for Diagnosis of Interventional Pulmonary Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10A6248

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8I7059

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15Y8668

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Chronic Thromboembolic Pulmonary Hypertension Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-13N6290

Global Chronic Thromboembolic Pulmonary Hypertension Market Research Report 2025

FEATURED COMPANIES

Chronic Thromboembolic Pulmonary Hypertension Market Size

Chronic Thromboembolic Pulmonary Hypertension Market

Scope of Chronic Thromboembolic Pulmonary Hypertension Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Chronic Thromboembolic Pulmonary Hypertension Market report?

What are the Application segmentation covered in the Chronic Thromboembolic Pulmonary Hypertension Market report?

What are the Type segmentation covered in the Chronic Thromboembolic Pulmonary Hypertension Market report?

FEATURED COMPANIES

RELATED REPORTS